ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1725

Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice

Gitanjali Lobo1, Juan Meng2, Xuhua Shi2, Ronak Patel3, Laura Rivers4, Chad Hille5, Robert Quinet6, William Davis7, Jerald Zakem8, Chandana Keshavamurthy9, Tamika Webb-Detiege10, Zongbing You2 and Xin Zhang11, 1Ochsner Clinic Foundation, Metairie, LA, 2Tulane University, New Orleans, LA, 3Ochsner, New Orleans, LA, 4Ochsner Medical Center, River Ridge, LA, 5Ochsner Clinic Foundation, New Orleans, LA, 6Ochsner Health, River Ridge, LA, 7Ochsner Medical Center, New Orleans, LA, 8Ochsner Health Systems, Metairie, LA, 9ochsner medical center, Metairie, LA, 10University of Queensland/Ochsner Clinical School, New Orleans, LA, 11Institution of Translational Research, Ochsner Health System, New Orleans, LA

Meeting: ACR Convergence 2022

Keywords: diet, Disease Activity, gender, Mouse Models, Lupus, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Animal Models Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic inflammation and the production of autoantibodies, leading to systemic multiorgan damage. SLE has been reported with diverse prevalence and clinical phenotypes of varying severity, which may be caused by sex hormones, genetic and epigenetic factors, and gut microbiota. Our recent studies showed that a high-fat diet (HFD) exacerbated lupus development and autoimmunity in MRL/lpr lupus-prone mice. Using this model, we investigated the gender bias in autoimmune progression and their systemic response to HFD.

Methods: Twenty male and twenty female MRL/lpr mice were evenly grouped and fed with a regular diet (RD, 10% fat-derived calories) or HFD (60% fat-derived calories). Their body weights were recorded weekly. SLE progression was monitored weekly by skin lesions, urine protein, IgG level, and titers of anti-dsDNA antibody (Ab) and anti-nuclear antibody (ANA) in serum. At week 14 the mice were euthanized. Their spleens were measured and weighed. Kidney and skin from the dorsum of the neck were fixed and embedded for H&E, PAS, and Masson’s staining for histopathological lupus lesions and quantified using kidney index and skin score.

Results: HFD induced a greater weight gain than RD. Additionally, the female group experienced more weight gain than the male group (p< 0.01). SLE skin rash showed up as early as week 6 in both male and female HFD groups. The female HFD group had a greater increase in histopathological skin score than the female RD group (p< 0.01), whereas there was no difference in respective male groups. Splenomegaly and proteinuria were only observed in male HFD mice. Although both males and females had higher serum IgG in the HFD group than the RD group, only the male HFD group showed an increased trend in anti-dsDNA Ab and ANA titers. Kidney pathological changes in the HFD group were more severe in male mice than in female mice, detected by significant increases of kidney index (p< 0.05) and glomerular cell proliferation (p< 0.05).

Conclusion: There is a significant difference of autoimmune progression in male compared to female lupus-prone mice in response to a high fat diet. Our results parallel many known clinical lupus phenotypes and sexual dimorphism in which male patients are more likely to have severe disease (such as nephritis) than female lupus patients, who may have a broader range of lupus symptoms. Elucidation of the cellular and molecular basis of the sex differences in response to a high fat diet in SLE may lead to personalized therapeutic treatment for lupus patients.


Disclosures: G. Lobo, None; J. Meng, None; X. Shi, None; R. Patel, None; L. Rivers, None; C. Hille, None; R. Quinet, None; W. Davis, None; J. Zakem, None; C. Keshavamurthy, None; T. Webb-Detiege, None; Z. You, None; X. Zhang, None.

To cite this abstract in AMA style:

Lobo G, Meng J, Shi X, Patel R, Rivers L, Hille C, Quinet R, Davis W, Zakem J, Keshavamurthy C, Webb-Detiege T, You Z, Zhang X. Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sex-differences-in-autoimmune-pathogenesis-and-systemic-response-to-high-fat-diet-in-lupus-prone-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-autoimmune-pathogenesis-and-systemic-response-to-high-fat-diet-in-lupus-prone-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology